Admission Date:  [**2200-12-15**]       Discharge Date:  [**2201-1-17**]  Date of Birth:   [**2200-12-15**]       Sex:  F  Service:  HISTORY OF PRESENT ILLNESS:  The patient is the 2420 gm product of a 34 [**3-9**] week gestation born to a 29 year old G1 P1 mother with prenatal screens of B positive, antibody negative, RPR nonreactive, rubella immune, hepatitis surface antigen negative, GBS unknown.
Therefore, delivered by cesarean section with rupture of membranes at delivery for clear fluid.
Received blow-by O2 and then developed some apnea which required positive pressure ventilation with several breaths.
Infant was transferred to the newborn intensive care unit for further management of prematurity.
She remained on CPAP for a total of 24 hours, weaned to nasal cannula on which she remained for 48 hours and has remained in room air throughout the remainder of her hospital course.
She has never required intervention for apnea or bradycardia of prematurity.
Enteral feedings were initiated on day of life one.
She achieved full enteral feedings by day of life eight and has been stable with full enteral feedings throughout her hospital course.
She has not required any blood transfusions during this hospital course.
Infant received 48 hours of antibiotics at which time blood cultures remained negative and antibiotics were discontinued at that time.
CARE RECOMMENDATIONS:  Continue ad lib feedings of Enfamil 24 calorie.
IMMUNIZATIONS:  The infant received hepatitis B vaccine on [**2200-12-24**] and will be due for dose #2 on [**2201-1-24**].
She received Synagis vaccine on [**2201-1-15**].
Next synagis dose is due [**2201-2-12**].
Recommended immunizations include Synagis RSV prophylaxis which should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the three following criteria: (1) born at less than 32 weeks; (2) born between 32 and 35 weeks with plans for daycare during RSV seasons, with smokers in the household or preschool sibs; (3) with chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach 6 months of age.
Before this age family and other caregivers should be considered for immunization against influenza to protect the infant.
